R.T.D. Oliver

16.4k total citations
325 papers, 10.4k citations indexed

About

R.T.D. Oliver is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R.T.D. Oliver has authored 325 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Surgery, 96 papers in Pulmonary and Respiratory Medicine and 72 papers in Molecular Biology. Recurrent topics in R.T.D. Oliver's work include Testicular diseases and treatments (92 papers), Prostate Cancer Treatment and Research (47 papers) and Bladder and Urothelial Cancer Treatments (42 papers). R.T.D. Oliver is often cited by papers focused on Testicular diseases and treatments (92 papers), Prostate Cancer Treatment and Research (47 papers) and Bladder and Urothelial Cancer Treatments (42 papers). R.T.D. Oliver collaborates with scholars based in United Kingdom, United States and Canada. R.T.D. Oliver's co-authors include Ken Jacobson, Micah Dembo, A.M.E. Nouri, Akira Ishihara, R.F. Hussain, J. P. BLANDY, H. F. Hope-Stone, Jonathan Shamash, A. Horwich and Daniel M. Berney and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

R.T.D. Oliver

318 papers receiving 10.0k citations

Peers

Countries citing papers authored by R.T.D. Oliver

Since Specialization

Citations

This map shows the geographic impact of R.T.D. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.T.D. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.T.D. Oliver more than expected).

Fields of papers citing papers by R.T.D. Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.T.D. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.T.D. Oliver. The network helps show where R.T.D. Oliver may publish in the future.

Co-authorship network of co-authors of R.T.D. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of R.T.D. Oliver. A scholar is included among the top collaborators of R.T.D. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.T.D. Oliver. R.T.D. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between Average Vitamin D Levels and COVID-19 Mortality in 19 European Countries—A Population-Based Study 2023 ·Nutrients ·Amar Ahmad, (unknown), (unknown), Christian Heumann, Raghib Ali, R.T.D. Oliver	6
2	The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis 2017 ·Clinical Cancer Research ·Lei Xu, Xueying Mao, Tianyu Guo, Pui Ying Chan, Greg Shaw, John Hines, Elzbieta Stankiewicz, Yuqin Wang, R.T.D. Oliver, Amar Ahmad, Daniel M. Berney, Jonathan Shamash, Yong‐Jie Lu	54
3	Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group 2013 ·European Urology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), R.T.D. Oliver, N. Antoniou, (unknown), (unknown), Chris Robertson	47
4	β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression 2011 ·Oncogene ·Sudha K. Shenoy, Seonggyun Han, Yangbing Zhao, Makoto R. Hara, R.T.D. Oliver, Yiting Cao, Mark W. Dewhirst	60
5	Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells 2010 ·Cancer Research ·(unknown), Lara K. Boyd, Xueying Mao, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, R.T.D. Oliver, Daniel M. Berney, Yong‐Jie Lu	78
6	Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis 2010 ·Cancer Research ·Xueying Mao, Yongwei Yu, Lara K. Boyd, Guoping Ren, Dongmei Lin, Tracy Chaplin, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, Liyan Xue, Luis Beltrán, Manu Gupta, R.T.D. Oliver, Nicholas R. Lemoine, Daniel M. Berney, Bryan D. Young, Yong‐Jie Lu	126
7	The CSROC Expert Panel. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy 2010 ·Susan Furness, Anne‐Marie Glenny, Helen V Worthington, Sue Pavitt, R.T.D. Oliver, Jan Clarkson, Michaelina Macluskey, Chan Kk, (unknown)	37
8	Impaired Macrophage Function Underscores Susceptibility to Salmonella in Mice Lacking Irgm1 (LRG-47) 2007 ·The Journal of Immunology ·Stanley C. Henry, (unknown), Maanasa Indaram, John F. Whitesides, Gregory D. Sempowski, David N. Howell, R.T.D. Oliver, Gregory A. Taylor	57
9	Molecular Positron Emission Tomography and PET/CT Imaging in Urological Malignancies 2007 ·European Urology ·Tom Powles, Iain Murray, Cathryn Brock, R.T.D. Oliver, Norbert Avril	110
10	Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity 2003 ·Oncogene ·Wai M. Liu, Thomas Powles, Jonathan Shamash, David Propper, R.T.D. Oliver, Simon Joel	41
11	CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. 2000 ·British Journal of Radiology ·S.A. Sohaib, (unknown), (unknown), M. A. Farquharson, R.T.D. Oliver, Rodney H. Reznek	131
12	Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial 1999 ·UCL Discovery (University College London) ·(unknown), Gareth Griffiths, (unknown), (unknown), (unknown), (unknown), Gregory S. Sibley, G.M. Mead, (unknown), Julie Owen, R.T.D. Oliver, Philip Smith, (unknown), Penny A. Cook, Peter Fayers, Paz Cook, (unknown), John Whitehead, (unknown), (unknown)	16
13	Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter 1997 ·British Journal of Cancer ·D. Papamichael, (unknown), R.T.D. Oliver, (unknown), Jacob Waxman	94
14	Castration-Induced Lymphocytosis in Prostate Cancer: Possible Evidence for Gonad/Thymus Endocrine Interaction in Man 1995 ·Urologia Internationalis ·R.T.D. Oliver, (unknown), Carla J. Gallagher	8
15	Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise 1994 ·BMJ ·D Forman, Malcolm C. Pike, G Davey, Sally J. Dawson, K. Adam Baker, Clair Chilvers, R.T.D. Oliver, Carol Coupland	253
16	Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis 1992 ·British Journal of Cancer ·D Forman, R.T.D. Oliver, (unknown), (unknown), (unknown), (unknown), CED Chilvers, MC Pike	140
17	Urological and genital cancer 1989 ·R.T.D. Oliver, J. P. BLANDY, H. F. Hope-Stone	25
18	Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. 1985 ·BMJ ·Jonathan Waxman, A. Man, W. F. HENDRY, H. N. WHITFIELD, G. M. Besser, R. C. Tiptaft, (unknown), R.T.D. Oliver	88
19	Factors contributing to delay in diagnosis of testicular tumours. 1985 ·BMJ ·R.T.D. Oliver	23
20	Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. 1983 ·BMJ ·Jonathan Waxman, J. A. H. Wass, W. F. HENDRY, H. N. WHITFIELD, G. M. Besser, J. S. Malpas, R.T.D. Oliver	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact